DUBLIN--(BUSINESS WIRE)--Sep 11, 2018--The "Hemophilia - Epidemiology Forecast to 2025" report has been added to ResearchAndMarkets.com's offering.

Hemophilia - Epidemiology Forecast To 2025 provides an overview of the epidemiology trends of Hemophilia in seven major markets (US, France, Germany, Italy, Spain, UK and Japan). It includes 10 years epidemiology historical and forecasted data of Hemophilia prevalent or incident cases segmented by age, sex and subpopulations. The report also discusses the prevailing risk factors, disease burden with special emphasis on the unmet medical need associated with the Hemophilia.

Scope of the report:

The report includes the prevalent population and how will it change over the next eight years.Prevalent or incident cases segmented by age and sex.Coverage of key Hemophilia subpopulations and its prevalent or incident cases The key differences in epidemiology patterns across the seven market segments

Key Topics Covered:

1. Report Introduction

2. Snapshot of Total Prevalent or Incident cases by 7 MM

3. Executive Summary4. Hemophilia Overview5. Etiology

6. Risk Factors Associated with Hemophilia

7. Disease Burden & Unmet Need in the Market

8. Epidemiology and Patient Populations9. Prevalent & Incident Cases by 7 MM-2015-202510. Key Takeaways

11. Appendix

For more information about this report visit https://www.researchandmarkets.com/research/7c42rl/global_hemophilia?w=4

View source version on businesswire.com:https://www.businesswire.com/news/home/20180911005406/en/

CONTACT: ResearchAndMarkets.com

Laura Wood, Senior Manager

press@researchandmarkets.com

For E.S.T Office Hours Call 1-917-300-0470

For U.S./CAN Toll Free Call 1-800-526-8630

For GMT Office Hours Call +353-1-416-8900

Related Topics:Hematological Drugs

KEYWORD:

INDUSTRY KEYWORD: HEALTH PHARMACEUTICAL

SOURCE: Research and Markets

Copyright Business Wire 2018.

PUB: 09/11/2018 07:22 AM/DISC: 09/11/2018 07:22 AM

http://www.businesswire.com/news/home/20180911005406/en